meprobamate has been researched along with Diabetes Mellitus in 2 studies
Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dowd, JE | 1 |
Glasunov, IS | 1 |
Jaksić, Z | 1 |
Kesić, B | 1 |
Ray, D | 1 |
Steinberger, C | 1 |
Stromberg, J | 1 |
Vuletić, S | 1 |
Hofmann, KW | 1 |
Manach, J | 1 |
Sögtrop, HH | 1 |
1 review available for meprobamate and Diabetes Mellitus
Article | Year |
---|---|
[Dipotassium chlorazepate. Clinical reports on a new anxiolytic].
Topics: Adult; Aged; Alcoholism; Automobile Driving; Cardiovascular Diseases; Diabetes Mellitus; Diazepam; D | 1970 |
1 other study available for meprobamate and Diabetes Mellitus
Article | Year |
---|---|
Design and methodology of the Zagreb preliminary study: response rates at the study stages.
Topics: Cardiovascular Diseases; Diabetes Mellitus; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperte | 1976 |